The Recall Desk
ModerateFDA (Devices)·Z-0859-2020·Announced 2020-02-05

Vitreq Bv Recalls VitreQ 23G Blunt Needles Due to Sterility Risk

Vitreq Bv is recalling VitreQ 23G Blunt Needles because microscopic tears in the sterile pouch may compromise sterility.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II and involves a potential sterility compromise without reported injuries or illnesses, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

Vitreq Bv is recalling VitreQ 23G Blunt Needles with luer-lock connector (REF: CN23.D05, GTIN: 8719214221621). The recall is being conducted because microscopic tears of the sterile pouch may compromise sterility.

The recall applies to all lots of the product. The distribution pattern is listed as nationwide. The agency classification for this recall is Class II.

Consumers and healthcare providers should stop using the affected needles and contact the recalling firm for further instructions.

The recalled product

Product
VitreQ 23G Blunt Needles with luer-lock connector-REF: CN23.D05 GTIN: 8719214221621
Manufacturer
Vitreq Bv

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 16 recalled by Vitreq Bv under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 16 products in this recall →